Literature DB >> 17236962

How does performance of ultrasound tissue typing affect design of prostate IMRT dose-painting protocols?

Pengpeng Zhang1, K Sunshine Osterman, Tian Liu, Xiang Li, Jack Kessel, Leester Wu, Peter Schiff, Gerald J Kutcher.   

Abstract

PURPOSE: To investigate how the performance characteristics of ultrasound tissue typing (UTT) affect the design of a population-based prostate dose-painting protocol. METHODS AND MATERIALS: The performance of UTT is evaluated using the receiver operating characteristic curve. As the imager's sensitivity increases, more tumors are detected, but the specificity worsens, causing more false-positive results. The UTT tumor map, obtained with a specific sensitivity and specificity setup, was used with the patient's CT image to guide intensity-modulated radiotherapy (IMRT) planning. The optimal escalation dose to the UTT positive region, as well as the safe dose to the negative background, was obtained by maximizing the uncomplicated control (i.e., a combination of tumor control probability and weighted normal tissue complication probability). For high- and low-risk tumors, IMRT plans guided by conventional ultrasound or UTT with a one-dimensional or two-dimensional spectrum analysis technique were compared with an IMRT plan in which the whole prostate was dose escalated.
RESULTS: For all imaging modalities, the specificity of 0.9 was chosen to reduce complications resulting from high false-positive results. If the primary tumors were low risk, the IMRT plans guided by all imaging modalities achieved high tumor control probability and reduced the normal tissue complication probability significantly compared with the plan with whole gland dose escalation. However, if the primary tumors were high risk, the accuracy of the imaging modality was critical to maintain the tumor control probability and normal tissue complication probability at acceptable levels.
CONCLUSION: The performance characteristics of an imager have important implications in dose painting and should be considered in the design of dose-painting protocols.

Entities:  

Mesh:

Year:  2007        PMID: 17236962      PMCID: PMC2901543          DOI: 10.1016/j.ijrobp.2006.08.061

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  IMRT dose shaping with regionally variable penalty scheme.

Authors:  Cristian Cotrutz; Lei Xing
Journal:  Med Phys       Date:  2003-04       Impact factor: 4.071

2.  Fitting of normal tissue tolerance data to an analytic function.

Authors:  C Burman; G J Kutcher; B Emami; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

3.  Computerized design of target margins for treatment uncertainties in conformal radiotherapy.

Authors:  G S Mageras; Z Fuks; S A Leibel; C C Ling; M J Zelefsky; H M Kooy; M van Herk; G J Kutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-15       Impact factor: 7.038

4.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

5.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

Authors:  A Niemierko; M Goitein
Journal:  Radiother Oncol       Date:  1993-11       Impact factor: 6.280

6.  MR-spectroscopy guided target delineation for high-grade gliomas.

Authors:  A Pirzkall; T R McKnight; E E Graves; M P Carol; P K Sneed; W W Wara; S J Nelson; L J Verhey; D A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-15       Impact factor: 7.038

7.  Reporting and analyzing dose distributions: a concept of equivalent uniform dose.

Authors:  A Niemierko
Journal:  Med Phys       Date:  1997-01       Impact factor: 4.071

8.  ROC analysis of ultrasound tissue characterization classifiers for breast cancer diagnosis.

Authors:  Smadar Gefen; Oleh J Tretiak; Catherine W Piccoli; Kevin D Donohue; Athina P Petropulu; P Mohana Shankar; Vishruta A Dumane; Lexun Huang; M Alper Kutay; Vladimir Genis; Flemming Forsberg; John M Reid; Barry B Goldberg
Journal:  IEEE Trans Med Imaging       Date:  2003-02       Impact factor: 10.048

9.  MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.

Authors:  Masaru Hasumi; Kazuhiro Suzuki; Nariyuki Oya; Kazuto Ito; Kohei Kurokawa; Yoshitatsu Fukabori; Hidetoshi Yamanaka
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

10.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

Authors:  S Webb; A E Nahum
Journal:  Phys Med Biol       Date:  1993-06       Impact factor: 3.609

View more
  1 in total

1.  Incorporate imaging characteristics into an arteriovenous malformation radiosurgery plan evaluation model.

Authors:  Pengpeng Zhang; Leester Wu; Tian Liu; Gerald J Kutcher; Steven Isaacson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-01       Impact factor: 7.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.